Key facts
- Chamber Cardio’s last known valuation is $130.0M (Feb 2026).
- It has raised $69.5M; the latest was Early Stage VC ($60.0M) in Feb 2026.
- Notable investors include General Catalyst, AlleyCorp, City Light Capital, Company Ventures, Optum Ventures — 9 tracked in total.
- Status: Privately Held (backing).
Leadership
- Brannan SchellExecutive
- Clayton MeyersHead
- Matthew TembaChief Technology Officer
- Sameer ShethExecutive & President
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Chamber Cardio
- ·The full record, as it builds
Funding rounds
No funding rounds for Chamber Cardio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Chamber Cardio
Operator of a healthcare platform intended to improve the services related to cardiovascular health and to transition cardiologists into value-based care. The company offers various services like panel management, including updates, financial metrics, and clinical data into a single platform, support via software to manage complex patients, and value-based contracting, enabling patients and the healthcare sector with complete support through improved software, and patients to get the treatment at the right time.
- Sector
- Healthcare
- HQ
- Washington, DC, United States
- Founded
- 2022
- Employees
- 47
- Website
- chambercardio.com/
- Ownership
- Privately Held (backing)
Chamber Cardio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Chamber Cardio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Chamber Cardio in its N-PORT filings yet. We sweep new filings monthly.